Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
28477 | 206 | 36.1 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
501 | 3 | SYSTEMIC SCLEROSIS//SCLERODERMA//IDIOPATHIC PULMONARY FIBROSIS | 22108 |
968 | 2 | IDIOPATHIC PULMONARY FIBROSIS//INTERSTITIAL LUNG DISEASE//PULMONARY FIBROSIS | 10678 |
28477 | 1 | PIRFENIDONE//FLUOROFENIDONE//STATE MED GENET CHINA | 206 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PIRFENIDONE | authKW | 4657374 | 40% | 38% | 82 |
2 | FLUOROFENIDONE | authKW | 1709002 | 7% | 82% | 14 |
3 | STATE MED GENET CHINA | address | 758917 | 8% | 32% | 16 |
4 | AKF PD | authKW | 592921 | 2% | 100% | 4 |
5 | 2 2 DIMETHYL 3 4 DIHYDRO 2H PYRROLE N OXIDE DMPO | authKW | 148230 | 0% | 100% | 1 |
6 | 21H PYRIDONE DERIVATIVES | authKW | 148230 | 0% | 100% | 1 |
7 | 5 CARBOXYPIRFENIDONE | authKW | 148230 | 0% | 100% | 1 |
8 | 5 HYDROXYPIRFENIDONE | authKW | 148230 | 0% | 100% | 1 |
9 | ANTI FIBROTIC AGENT ADHESIONS PERITONEAL | authKW | 148230 | 0% | 100% | 1 |
10 | ARTMENT VET SURG RADIOL | address | 148230 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 578 | 32% | 0% | 66 |
2 | Transplantation | 338 | 9% | 0% | 18 |
3 | Urology & Nephrology | 200 | 10% | 0% | 20 |
4 | Respiratory System | 101 | 6% | 0% | 13 |
5 | Immunology | 81 | 11% | 0% | 23 |
6 | Surgery | 47 | 10% | 0% | 21 |
7 | Biochemical Research Methods | 36 | 5% | 0% | 11 |
8 | Ophthalmology | 30 | 4% | 0% | 8 |
9 | Toxicology | 30 | 4% | 0% | 9 |
10 | Physiology | 26 | 5% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STATE MED GENET CHINA | 758917 | 8% | 32% | 16 |
2 | ARTMENT VET SURG RADIOL | 148230 | 0% | 100% | 1 |
3 | CHANGSHA CENT HOSP | 148230 | 0% | 100% | 1 |
4 | FARM BIOMED IBUBNUCL UNIV PEDRALBES | 148230 | 0% | 100% | 1 |
5 | ORAL MAXILLO IAL SURGSHANGHAI ST | 148230 | 0% | 100% | 1 |
6 | PHARMACY UNION HOSP | 148230 | 0% | 100% | 1 |
7 | STATE OPHTHALMOL GLAUCOMA | 148230 | 0% | 100% | 1 |
8 | SURG KIDNEY SHINJUKU KU | 148230 | 0% | 100% | 1 |
9 | UNITAT FARCAL FARMACOGNOSIA | 148230 | 0% | 100% | 1 |
10 | VET AFFAIRS SAN DIEGO HEALTHCARE SYST MED | 148230 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 1601 | 2% | 0% | 4 |
2 | NEPHROLOGY | 1090 | 2% | 0% | 4 |
3 | PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY | 722 | 1% | 0% | 2 |
4 | RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY | 710 | 1% | 0% | 2 |
5 | BIOPHARMACEUTICS & DRUG DISPOSITION | 688 | 1% | 0% | 3 |
6 | NATURE REVIEWS DRUG DISCOVERY | 629 | 1% | 0% | 2 |
7 | MULTIPLE SCLEROSIS JOURNAL | 565 | 1% | 0% | 3 |
8 | INTERNATIONAL IMMUNOPHARMACOLOGY | 543 | 2% | 0% | 4 |
9 | DRUG DESIGN DEVELOPMENT AND THERAPY | 424 | 1% | 0% | 2 |
10 | MOLECULAR VISION | 401 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRAIM, AEP , MACDONALD, MH , BRUSS, ML , STANLEY, SD , GIRI, JK , GIRI, SN , (2008) PHARMACOKINETICS AND CLINICAL EFFECTS OF PIRFENIDONE ADMINISTERED INTRAVENOUSLY IN HORSES.AMERICAN JOURNAL OF VETERINARY RESEARCH. VOL. 69. ISSUE 7. P. 952-960 | 27 | 66% | 2 |
2 | LASKY, J , (2004) PIRFENIDONE INTERMUNE/SHIONOGI/MARNAC.IDRUGS. VOL. 7. ISSUE 2. P. 166-172 | 24 | 75% | 22 |
3 | SHI, SJ , WU, JH , WU, J , ZENG, FD , (2009) DEVELOPMENT AND VALIDATION OF AN IMPROVED LC METHOD FOR THE SIMULTANEOUS DETERMINATION OF PIRFENIDONE AND ITS CARBOXYLIC ACID METABOLITE IN HUMAN PLASMA.CHROMATOGRAPHIA. VOL. 69. ISSUE 5-6. P. 459 -463 | 18 | 82% | 2 |
4 | WANG, YS , ZHAO, XP , ZHONG, J , CHEN, Y , LIU, XQ , WANG, GJ , (2006) SIMPLE DETERMINATION OF PIRFENIDONE IN RAT PLASMA VIA HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.BIOMEDICAL CHROMATOGRAPHY. VOL. 20. ISSUE 12. P. 1375-1379 | 15 | 100% | 10 |
5 | TONG, SH , WANG, XQ , JIANG, HY , XU, XG , PAN, YB , CHEN, KM , WU, J , XU, QQ , DENG, J , HU, GX , (2010) DETERMINATION OF PIRFENIDONE IN RAT PLASMA BY LC-MS-MS AND ITS APPLICATION TO A PHARMACOKINETIC STUDY.CHROMATOGRAPHIA. VOL. 71. ISSUE 7-8. P. 709 -713 | 15 | 88% | 3 |
6 | MAHER, TM , (2010) PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS.DRUGS OF TODAY. VOL. 46. ISSUE 7. P. 473-482 | 24 | 50% | 27 |
7 | DOSANJH, A , (2007) PIRFENIDONE: A NOVEL POTENTIAL THERAPEUTIC AGENT IN THE MANAGEMENT OF CHRONIC ALLOGRAFT REJECTION.TRANSPLANTATION PROCEEDINGS. VOL. 39. ISSUE 7. P. 2153-2156 | 18 | 75% | 7 |
8 | BRAIM, AEP , MACDONALD, MH , BRUSS, ML , GRATTENDICK, KJ , GIRI, SN , MARGOLIN, SB , (2009) EFFECTS OF INTRAVENOUS ADMINISTRATION OF PIRFENIDONE ON HORSES WITH EXPERIMENTALLY INDUCED ENDOTOXEMIA.AMERICAN JOURNAL OF VETERINARY RESEARCH. VOL. 70. ISSUE 8. P. 1031-1042 | 25 | 47% | 8 |
9 | THORAT, SG , CHIKHALE, RV , (2016) DETERMINATION AND PHARMACOKINETIC STUDY OF PIRFENIDONE IN RAT SERUM BY HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY.JOURNAL OF CHROMATOGRAPHIC SCIENCE. VOL. 54. ISSUE 7. P. 1115 -1119 | 9 | 90% | 0 |
10 | CARTER, NJ , (2011) PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS.DRUGS. VOL. 71. ISSUE 13. P. 1721 -1732 | 13 | 59% | 33 |
Classes with closest relation at Level 1 |